Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
doi: https://doi.org/10.1101/2021.03.11.21253375
Madison Stoddard
1Fractal Therapeutics Inc, Cambridge, MA, USA
Lin Yuan
1Fractal Therapeutics Inc, Cambridge, MA, USA
Arijit Chakravarty
1Fractal Therapeutics Inc, Cambridge, MA, USA

Data Availability
The work describes a mathematical methodology based on publicly available data. All data used in the work was sourced from prior publications.
Posted March 12, 2021.
Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
medRxiv 2021.03.11.21253375; doi: https://doi.org/10.1101/2021.03.11.21253375
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (579)
- Anesthesia (140)
- Cardiovascular Medicine (1947)
- Dermatology (184)
- Emergency Medicine (333)
- Epidemiology (11102)
- Gastroenterology (624)
- Genetic and Genomic Medicine (3168)
- Geriatric Medicine (309)
- Health Economics (561)
- Health Informatics (2042)
- Health Policy (863)
- Hematology (310)
- HIV/AIDS (682)
- Medical Education (317)
- Medical Ethics (92)
- Nephrology (334)
- Neurology (2986)
- Nursing (164)
- Nutrition (463)
- Oncology (1552)
- Ophthalmology (477)
- Orthopedics (185)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (912)
- Primary Care Research (355)
- Public and Global Health (5591)
- Radiology and Imaging (1094)
- Respiratory Medicine (760)
- Rheumatology (339)
- Sports Medicine (289)
- Surgery (343)
- Toxicology (48)
- Transplantation (159)
- Urology (132)